Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (1)
• Plasma (double spun) (1)
• Plasma (single spun) (3)
• Saliva (1)
• Serum (4)
• Stool (2)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (9)

Storage Temperature

• -35°C to -18°C (5)
• -85°C to -60°C (6)
• Liquid nitrogen (1)

Associated Data

• Biomarker datasets (2)
• Clinical records (4)
• Followup records (4)
• Freezer temperature logs (4)
• Genomic datasets (2)
• Imaging data (2)
• Microbiological results (4)
• Participant Ethnicity (3)
• Pre-analytical data (1)
• Quality indicators (2)
• Survey data (6)
• Treatment records (4)

Timeframe

• Immediate (2)
• 0 - 3 months (7)
• 3 - 6 months (2)
• > 6 months (2)

Participant Count

• 11 - 100 (9)

Sex

• Both sexes (9)

Age Range

• Infant (1 month - 2 years) (1)
• Young child (2 - 6 years) (2)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (5)
• Young adult (18 - 40 years) (5)
• Adult (> 40 years) (6)

Biobank Services

• Cell culture (1)
• Data analytics (1)
• Digital imaging (1)
• Infectious strain isolation (2)
• Molecular Extractions (1)
• Nucleic acid extraction (4)

Collection Type

• Case-control (2)
• Clinical Trial (1)
• Cross-sectional (3)
• Disease specific (4)
• Longitudinal (1)

Consent Restriction

• No Commercial restriction (6)
• No Disease area restriction (9)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (8)
• No Scope of use restriction (7)

Collection Status

• Completed (5)
• In progress (4)
• Not-started (1)

Access Condition

• Open to applicants (5)
• Open only through collaboration (2)
• Access restricted at present (2)

Country

• Belgium (1)
• Cameroon (1)
• Côte d'Ivoire (1)
• France (1)
• India (1)
• Kenya (2)
• United States (2)

County